WellPoint Inc (WLP): Today's Featured Health Care Loser

WellPoint ( WLP) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 1.5%. By the end of trading, WellPoint fell $1.49 (-2.2%) to $67.30 on average volume. Throughout the day, 3.3 million shares of WellPoint exchanged hands as compared to its average daily volume of three million shares. The stock ranged in price between $67.09-$68.46 after having opened the day at $68.27 as compared to the previous trading day's close of $68.79. Other company's within the Health Care sector that declined today were: Health Net ( HNT), down 24.9%, Cormedix ( CRMD), down 23.1%, Chemocentryx ( CCXI), down 18%, and Prestige Brands Holdings ( PBH), down 15.2%.

WellPoint, Inc., through its subsidiaries, operates as a health benefits company in the United States. The company offers various network-based managed care plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $22.63 billion and is part of the health services industry. The company has a P/E ratio of 9.3, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 3.8% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate WellPoint a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, growth in earnings per share and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Kensey Nash Corporation ( KNSY), up 32.1%, AtriCure ( ATRC), up 20.6%, MediciNova ( MNOV), up 11.3%, and LHC Group ( LHCG), up 10.2%, were all gainers within the health care sector with AstraZeneca ( AZN) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).